Insider-Trading
Aktuelle Insider-Transaktionen (SEC Form 4) — Käufe und Verkäufe von Vorständen, Direktoren und Großaktionären.
| Ticker | Insider | Funktion | Datum | Transaktion | Kurs ($) | Stück | Wert ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| SCHW | Schwab Charles R. | Co-Chairman | 04.08.2026 | Verkauf | 106,08 | 47.650 | 5.054.569 | Form 4 |
| STOK | Ticho Barry | CHIEF MEDICAL OFFICER | 03.08.2026 | Verkauf | 29,45 | 1.269 | 37.377 | Form 4 |
| STOK | Ticho Barry | CHIEF MEDICAL OFFICER | 03.08.2026 | Verkauf | 28,95 | 5.907 | 171.008 | Form 4 |
| SFIX | Bacos Anthony | Chief Prod/Technology Officer | 03.08.2026 | Verkauf | 4,09 | 20.000 | 81.722 | Form 4 |
| SFIX | Bacos Anthony | Chief Prod/Technology Officer | 03.08.2026 | Verkauf | 4,09 | 50.000 | 204.355 | Form 4 |
| SFIX | Bacos Anthony | Chief Prod/Technology Officer | 03.08.2026 | Optionsausübung | 2,48 | 50.000 | 124.000 | Form 4 |
| SARO | Ford Russell Wayne | Chief Executive Officer | 03.08.2026 | Verkauf | 30,04 | 10.969 | 329.501 | Form 4 |
| SYRE | Burrows Scott L | Chief Financial Officer | 03.08.2026 | Verkauf | 97,10 | 100 | 9.710 | Form 4 |
| SYRE | Burrows Scott L | Chief Financial Officer | 03.08.2026 | Verkauf | 96,30 | 2.300 | 221.490 | Form 4 |
| SYRE | Burrows Scott L | Chief Financial Officer | 03.08.2026 | Verkauf | 95,21 | 5.100 | 485.571 | Form 4 |
| SYRE | Burrows Scott L | Chief Financial Officer | 03.08.2026 | Optionsausübung | 14,50 | 7.500 | 108.750 | Form 4 |
| SYRE | Turtle Cameron | Chief Executive Officer | 03.08.2026 | Verkauf | 97,46 | 16 | 1.559 | Form 4 |
| SYRE | Turtle Cameron | Chief Executive Officer | 03.08.2026 | Verkauf | 96,82 | 1.392 | 134.773 | Form 4 |
| SYRE | Turtle Cameron | Chief Executive Officer | 03.08.2026 | Verkauf | 95,93 | 5.635 | 540.566 | Form 4 |
| SYRE | Turtle Cameron | Chief Executive Officer | 03.08.2026 | Verkauf | 95,10 | 7.157 | 680.631 | Form 4 |
| SYRE | Turtle Cameron | Chief Executive Officer | 03.08.2026 | Verkauf | 93,97 | 800 | 75.176 | Form 4 |
| SFM | Sinclair Jack | Chief Executive Officer | 03.08.2026 | Verkauf | 89,34 | 10.788 | 963.757 | Form 4 |
| SFM | Sinclair Jack | Chief Executive Officer | 03.08.2026 | Optionsausübung | 16,47 | 10.788 | 177.678 | Form 4 |
| SPT | Rankin Aaron Edward Frederick | Chief Technology Officer | 03.08.2026 | Zuteilung | — | 120.192 | — | Form 4 |
| SPOT | Norstrom Alex | Co-Chief Executive Officer | 03.08.2026 | Verkauf | 506,04 | 315 | 159.404 | Form 4 |
| SPOT | Norstrom Alex | Co-Chief Executive Officer | 03.08.2026 | Verkauf | 503,86 | 254 | 127.979 | Form 4 |
| SPOT | Norstrom Alex | Co-Chief Executive Officer | 03.08.2026 | Verkauf | 502,86 | 1.159 | 582.812 | Form 4 |
| SPOT | Norstrom Alex | Co-Chief Executive Officer | 03.08.2026 | Verkauf | 502,05 | 1.865 | 936.314 | Form 4 |
| SPOT | Norstrom Alex | Co-Chief Executive Officer | 03.08.2026 | Verkauf | 501,16 | 1.253 | 627.951 | Form 4 |
| SPOT | Norstrom Alex | Co-Chief Executive Officer | 03.08.2026 | Verkauf | 499,96 | 590 | 294.975 | Form 4 |
| SPOT | Norstrom Alex | Co-Chief Executive Officer | 03.08.2026 | Optionsausübung | 151,25 | 5.436 | 822.195 | Form 4 |
| SPOT | Soderstrom Gustav | Co-Chief Executive Officer | 03.08.2026 | Verkauf | 511,64 | 706 | 361.218 | Form 4 |
| SPOT | Soderstrom Gustav | Co-Chief Executive Officer | 03.08.2026 | Verkauf | 510,94 | 4.089 | 2.089.223 | Form 4 |
| SPOT | Soderstrom Gustav | Co-Chief Executive Officer | 03.08.2026 | Verkauf | 510,00 | 2.235 | 1.139.844 | Form 4 |
| SPOT | Soderstrom Gustav | Co-Chief Executive Officer | 03.08.2026 | Verkauf | 508,99 | 2.377 | 1.209.878 | Form 4 |
| SPOT | Soderstrom Gustav | Co-Chief Executive Officer | 03.08.2026 | Verkauf | 508,19 | 2.224 | 1.130.210 | Form 4 |
| SPOT | Soderstrom Gustav | Co-Chief Executive Officer | 03.08.2026 | Verkauf | 506,87 | 2.054 | 1.041.112 | Form 4 |
| SPOT | Soderstrom Gustav | Co-Chief Executive Officer | 03.08.2026 | Verkauf | 506,04 | 1.553 | 785.878 | Form 4 |
| SPOT | Soderstrom Gustav | Co-Chief Executive Officer | 03.08.2026 | Verkauf | 504,76 | 242 | 122.152 | Form 4 |
| SPOT | Soderstrom Gustav | Co-Chief Executive Officer | 03.08.2026 | Verkauf | 504,03 | 600 | 302.419 | Form 4 |
| SPOT | Soderstrom Gustav | Co-Chief Executive Officer | 03.08.2026 | Verkauf | 502,90 | 1.574 | 791.570 | Form 4 |
| SPOT | Soderstrom Gustav | Co-Chief Executive Officer | 03.08.2026 | Verkauf | 502,07 | 1.666 | 836.444 | Form 4 |
| SPOT | Soderstrom Gustav | Co-Chief Executive Officer | 03.08.2026 | Verkauf | 501,17 | 744 | 372.869 | Form 4 |
| SPOT | Soderstrom Gustav | Co-Chief Executive Officer | 03.08.2026 | Verkauf | 500,03 | 769 | 384.520 | Form 4 |
| SPOT | Soderstrom Gustav | Co-Chief Executive Officer | 03.08.2026 | Optionsausübung | 151,25 | 20.833 | 3.150.991 | Form 4 |
| SPIR | Mellinger Eric M. | Chief Commercial Officer | 03.08.2026 | Zuteilung | — | 150.000 | — | Form 4 |
| SNOW | Kleinerman Christian | EVP, Product Management | 03.08.2026 | Verkauf | 300,00 | 5.000 | 1.500.000 | Form 4 |
| SLDE | Gries Robert JR | Director | 03.08.2026 | Verkauf | 20,33 | 28.212 | 573.550 | Form 4 |
| SEPN | Long Daniel D. | SVP, Drug Discovery | 03.08.2026 | Verkauf | 34,68 | 2.334 | 80.944 | Form 4 |
| SEPN | Long Daniel D. | SVP, Drug Discovery | 03.08.2026 | Verkauf | 33,98 | 1.000 | 33.976 | Form 4 |
| SEPN | Long Daniel D. | SVP, Drug Discovery | 03.08.2026 | Optionsausübung | 2,76 | 1.518 | 4.190 | Form 4 |
| SEPN | Long Daniel D. | SVP, Drug Discovery | 03.08.2026 | Optionsausübung | 2,76 | 1.816 | 5.012 | Form 4 |
| SNDR | Rourke Mark B. | Executive Chair | 03.08.2026 | Verkauf | 35,18 | 20.312 | 714.503 | Form 4 |
| SNDR | Rourke Mark B. | Executive Chair | 03.08.2026 | Optionsausübung | 24,81 | 20.312 | 503.941 | Form 4 |
| SPFI | Campbell Richard D | Director | 03.08.2026 | Verkauf | 44,75 | 132.714 | 5.938.952 | Form 4 |
| SKYW | Steel Wade J | CHIEF COMMERCIAL OFFICER | 03.08.2026 | Verkauf | 111,44 | 22.000 | 2.451.676 | Form 4 |
| SIBN | Dunn Jeffrey W | Director | 03.08.2026 | Verkauf | 18,46 | 20.000 | 369.214 | Form 4 |
| SIBN | Dunn Jeffrey W | Director | 03.08.2026 | Optionsausübung | 4,68 | 20.000 | 93.600 | Form 4 |
| SI | Gilde Healthcare Holding B.V. | 10% Owner | 03.08.2026 | Verkauf | 22,71 | 10.751 | 244.155 | Form 4 |
| SHBI | Lamon John | Director | 03.08.2026 | Kauf | 24,57 | 300 | 7.371 | Form 4 |
| SMG | Hagedorn Partnership, L.P. | Director | 03.08.2026 | Verkauf | 68,16 | 1.207 | 82.271 | Form 4 |
| SMG | Hagedorn Partnership, L.P. | Director | 03.08.2026 | Verkauf | 67,42 | 28.793 | 1.941.322 | Form 4 |
| SYF | Gentleman Courtney | See remarks | 03.08.2026 | Verkauf | 76,73 | 721 | 55.322 | Form 4 |
| SYF | Owens Darrell | See remarks | 03.08.2026 | Verkauf | 76,73 | 610 | 46.805 | Form 4 |
| SYF | Coviello Arthur W Jr | Director | 03.08.2026 | Verkauf | 77,17 | 4.000 | 308.680 | Form 4 |
Kompakter Markt-Überblick — keine Anlageberatung. Quelle: Fundamentaldaten & SEC-Berichte (Geschäfts- und Quartalsberichte, 10-K/10-Q).